SBET vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 23, 2026

SBET

52.3
AI Score
VS
HIVE Wins

HIVE

54.8
AI Score

Investment Advisor Scores

SBET

52score
Recommendation
BUY

HIVE

55score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric SBET HIVE Winner
Forward P/E 196.0784 62.8931 HIVE
PEG Ratio 0 0 Tie
Revenue Growth 1553.9% 73.5% SBET
Earnings Growth 0.0% -99.9% SBET
Tradestie Score 52.3/100 54.8/100 HIVE
Profit Margin 0.0% -98.5% SBET
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD SBET

Relative Price Performance (Last 90 Days)

SBET 1M: -19.9% · 3M: +35.3% HIVE 1M: -42.1% · 3M: -34.1%

Current Technical Phase

SBET

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 43

RSI (14): 42.8 · Price: $7.86

HIVE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -4.7%), weak momentum, RSI 24

RSI (14): 23.9 · Price: $1.95

Fundamentals Snapshot

Metric SBET HIVE
Market Cap — —
Forward P/E -131.0 -3.8
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 15.5% 0.7%
Gross Margin 1.0% 0.4%
Operating Margin -27.5% -0.6%
EPS -11.91 -1.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.